2018 Speaking Faculty



Sabrina Aery
Sabrina Aery
Director 340B Compliance and State Policy Value, Access & Payment
Bristol-Myers Squibb


Don Bell
Don Bell
Senior Vice President
National Association Chain Drug Stores


Photo Not Available
Odalys Caprisecca
Senior Director, US Pricing & Government Relations
AstraZeneca


Jonathan Connell
Jonathan Connell, JD, MBA
Associate General Counsel
Bristol-Myers Squibb


Alice Valder Curran
Alice Valder Curran
Partner
Hogan Lovell


Cynthia Denemark
Cynthia Denemark
Director Pharmacy Services
Delaware Health and Social Services


Kristin Hicks
Kristin Hicks
Partner
Arnold & Porter Kaye Scholer LLP


Felicity Homsted
Felicity Homsted, PharmD, BCPS
Chief Pharmacy Officer
Penobscot Community Health Care


Ann Maxwell
Ann Maxwell
Assistant Inspector General for Evaluation and Inspections
Ofice of Inspector General (OIG)


Brian McCartney
Brian McCartney
Director, Government Pricing and Reporting
AstraZeneca


Natalie Morris
Natalie Morris
Director of Federal Government Affairs & Policy
AstraZeneca


Josh O'Harra
Josh O'Harra
Associate General Counsel
Eli Lilly


Stephen E. Ruscus
Stephen E. Ruscus
Partner
Morgan, Lewis & Bockius LLP


William Sarraille
William Sarraille
Partner
Sidley Austin LLP


John Shakow
John Shakow
Partner
King & Spalding


John Stancil
John Stancil, R.Ph.
Director of Pharmacy
North Carolina Department of Health and Human Services


Amanda Tucker
Amanda Tucker
Senior Government Analyst
UCB


William H. von Oehsen
William H. von Oehsen
Principal
Powers Pyles Sutter & Verville, PC


Debbie Walters
Debbie Walters
Vice President Assistant General Counsel
Pfizer


Charles Washington
Charles Washington, CFE, CPP, CICA
Director, America’s Compliance Division
Pfizer


Donna Lee Yesner
Donna Lee Yesner
Senior Counsel, Morgan
Lewis & Bockius LLP


Michele Zarychta
Michele Zarychta
Corporate Counsel
Pfizer